Axsome Shares Have Fallen Nearly 20% Over the Past Month
Axsome Therapeutics shares were up 5% at the time of writing after falling nearly 20% over the past month. The report cites concerns about the launch of its Alzheimer's disease agitation treatment.
Shares of Axsome Therapeutics (AXSM) have declined nearly 20% over the past month, but Wall Street believes the selloff may be excessive despite concerns surrounding the company’s Alzheimer's disease agitation treatment launch.AXSM stock was up 5% at the time of writing, having fallen to a 52-week…